Edexcel A-Level Biology A 9BN0
Lifestyle, Health and Risk
Genes and Health
Voice of the Genome
Biodiversity and Natural Resources
On the Wild Side
Immunity, Infection and Forensics
Run for Your Life
Grey Matter
Lifestyle, Health and Risk
Treatments for CVD, and cholesterol transport
- 3 things to know
- Papers 1, 2 and 3
Overview
Recall questions on antihypertensives, statins, anticoagulants and platelet inhibitors and their risks, and on the roles of HDL and LDL.
What you need to know
Answer each one before you reveal it.
Describe the role of high-density lipoproteins (HDLs) in cholesterol transport.
How do antihypertensives reduce CVD risk?
Questions from this subtopic
Each one with the model answer underneath.
- 1
How do antihypertensives reduce CVD risk?
Model answer
By lowering blood pressure, which decreases strain on arterial walls.
- 2
State three possible risks associated with taking antihypertensives.
Model answer
Dizziness, headaches, and allergic reactions.
- 3
Explain the mechanism by which statins reduce blood LDL cholesterol levels.
Model answer
Statins inhibit an enzyme involved in cholesterol synthesis in the liver, lowering blood LDL cholesterol.
- 4
State three risks associated with taking statins.
Model answer
Muscle pain, liver damage, and increased risk of type 2 diabetes.
- 5
How do anticoagulants reduce the risk of cardiovascular disease?
Model answer
By decreasing blood clot formation, preventing blockage of narrowed arteries.
- 6
What are the risks associated with anticoagulant use?
Model answer
Excessive bleeding and difficulty controlling bleeding from wounds.
Other ways to work this
The same content, four other ways.
What is inside Levo
Six ways to work the same material.
Every question in Lifestyle, Health and Risk, on a schedule.
Attempt a question from memory, write the correct version, then attempt it again. Levo records the jump between your first attempt and your last, and brings each question back on the day you are due to forget it.
Or £46 a year, about £3.83 a month. Cancel anytime.